Literature DB >> 24224999

18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.

Nikhil V Joshi1, Alex T Vesey2, Michelle C Williams2, Anoop S V Shah2, Patrick A Calvert3, Felicity H M Craighead2, Su Ern Yeoh2, William Wallace2, Donald Salter2, Alison M Fletcher2, Edwin J R van Beek2, Andrew D Flapan4, Neal G Uren4, Miles W H Behan4, Nicholas L M Cruden4, Nicholas L Mills2, Keith A A Fox2, James H F Rudd3, Marc R Dweck2, David E Newby2.   

Abstract

BACKGROUND: The use of non-invasive imaging to identify ruptured or high-risk coronary atherosclerotic plaques would represent a major clinical advance for prevention and treatment of coronary artery disease. We used combined PET and CT to identify ruptured and high-risk atherosclerotic plaques using the radioactive tracers (18)F-sodium fluoride ((18)F-NaF) and (18)F-fluorodeoxyglucose ((18)F-FDG).
METHODS: In this prospective clinical trial, patients with myocardial infarction (n=40) and stable angina (n=40) underwent (18)F-NaF and (18)F-FDG PET-CT, and invasive coronary angiography. (18)F-NaF uptake was compared with histology in carotid endarterectomy specimens from patients with symptomatic carotid disease, and with intravascular ultrasound in patients with stable angina. The primary endpoint was the comparison of (18)F-fluoride tissue-to-background ratios of culprit and non-culprit coronary plaques of patients with acute myocardial infarction.
FINDINGS: In 37 (93%) patients with myocardial infarction, the highest coronary (18)F-NaF uptake was seen in the culprit plaque (median maximum tissue-to-background ratio: culprit 1·66 [IQR 1·40-2·25] vs highest non-culprit 1·24 [1·06-1·38], p<0·0001). By contrast, coronary (18)F-FDG uptake was commonly obscured by myocardial uptake and where discernible, there were no differences between culprit and non-culprit plaques (1·71 [1·40-2·13] vs 1·58 [1·28-2·01], p=0·34). Marked (18)F-NaF uptake occurred at the site of all carotid plaque ruptures and was associated with histological evidence of active calcification, macrophage infiltration, apoptosis, and necrosis. 18 (45%) patients with stable angina had plaques with focal (18)F-NaF uptake (maximum tissue-to-background ratio 1·90 [IQR 1·61-2·17]) that were associated with more high-risk features on intravascular ultrasound than those without uptake: positive remodelling (remodelling index 1·12 [1·09-1·19] vs 1·01 [0·94-1·06]; p=0·0004), microcalcification (73% vs 21%, p=0·002), and necrotic core (25% [21-29] vs 18% [14-22], p=0·001).
INTERPRETATION: (18)F-NaF PET-CT is the first non-invasive imaging method to identify and localise ruptured and high-risk coronary plaque. Future studies are needed to establish whether this method can improve the management and treatment of patients with coronary artery disease. FUNDING: Chief Scientist Office Scotland and British Heart Foundation.
Copyright © 2014 Joshi et al. Open Access article distributed under the terms of CC BY. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24224999     DOI: 10.1016/S0140-6736(13)61754-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  306 in total

Review 1.  Coronary Artery Plaque Imaging.

Authors:  Yibin Xie; Hang Jin; Mengsu Zeng; Debiao Li
Journal:  Curr Atheroscler Rep       Date:  2017-09       Impact factor: 5.113

Review 2.  Determination of the Input Function at the Entry of the Tissue of Interest and Its Impact on PET Kinetic Modeling Parameters.

Authors:  M'hamed Bentourkia
Journal:  Mol Imaging Biol       Date:  2015-12       Impact factor: 3.488

3.  Pessimistic prophets.

Authors:  H William Strauss; Jagat Narula
Journal:  J Nucl Cardiol       Date:  2015-11-05       Impact factor: 5.952

4.  Debate: Molecular cardiac imaging is ready for the prime time con between wishful thinking and reality.

Authors:  Ignasi Carrió
Journal:  J Nucl Cardiol       Date:  2015-11-05       Impact factor: 5.952

Review 5.  "Eat me" imaging and therapy.

Authors:  Vaishali Bagalkot; Jeffrey A Deiuliis; Sanjay Rajagopalan; Andrei Maiseyeu
Journal:  Adv Drug Deliv Rev       Date:  2016-01-27       Impact factor: 15.470

6.  18F-Sodium Fluoride PET Imaging Passes an Important Milestone Toward Noninvasive Prediction of Clinical Events.

Authors:  Zahi A Fayad; Philip M Robson
Journal:  J Am Coll Cardiol       Date:  2020-06-23       Impact factor: 24.094

Review 7.  Multimodality imaging for the prevention of cardiovascular events: Coronary artery calcium and beyond.

Authors:  Duygu Kocyigit; Alexandra Scanameo; Bo Xu
Journal:  Cardiovasc Diagn Ther       Date:  2021-06

8.  Coronary plaque burden regression and high-risk plaque reversal: Potential biomarkers for secondary prevention?

Authors:  Janet Wei; Daniel S Berman; Debiao Li
Journal:  Trends Cardiovasc Med       Date:  2015-08-18       Impact factor: 6.677

9.  18F-Sodium Fluoride Positron Emission Tomography and Plaque Calcification.

Authors:  Sina Tavakoli; Mehran M Sadeghi
Journal:  Circ Cardiovasc Imaging       Date:  2019-01       Impact factor: 7.792

Review 10.  Imaging the myocardial ischemic cascade.

Authors:  Arthur E Stillman; Matthijs Oudkerk; David A Bluemke; Menko Jan de Boer; Jens Bremerich; Ernest V Garcia; Matthias Gutberlet; Pim van der Harst; W Gregory Hundley; Michael Jerosch-Herold; Dirkjan Kuijpers; Raymond Y Kwong; Eike Nagel; Stamatios Lerakis; John Oshinski; Jean-François Paul; Riemer H J A Slart; Vinod Thourani; Rozemarijn Vliegenthart; Bernd J Wintersperger
Journal:  Int J Cardiovasc Imaging       Date:  2018-03-19       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.